Cargando…
Luteolin Ameliorates Experimental Pulmonary Arterial Hypertension via Suppressing Hippo-YAP/PI3K/AKT Signaling Pathway
Luteolin is a flavonoid compound with a variety of pharmacological effects. In this study, we explored the effects of luteolin on monocrotaline (MCT) induced rat pulmonary arterial hypertension (PAH) and underlying mechanisms. A rat PAH model was generated through MCT injection. In this model, luteo...
Autores principales: | Zuo, Wanyun, Liu, Na, Zeng, Yunhong, Xiao, Zhenghui, Wu, Keke, Yang, Fan, Li, Biao, Song, Qingqing, Xiao, Yunbin, Liu, Qiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082250/ https://www.ncbi.nlm.nih.gov/pubmed/33935785 http://dx.doi.org/10.3389/fphar.2021.663551 |
Ejemplares similares
-
Tetramethylpyrazine Ameliorates Peritoneal Angiogenesis by Regulating VEGF/Hippo/YAP Signaling
por: Zhu, Xiaolin, et al.
Publicado: (2021) -
Integrated analysis of m(6)A mRNA methylation in rats with monocrotaline-induced pulmonary arterial hypertension
por: Zeng, Yunhong, et al.
Publicado: (2021) -
COVID-19 vaccination for children with pulmonary hypertension: efficacy, safety and reasons for opting against vaccination
por: Zhang, Zeying, et al.
Publicado: (2023) -
Meta-Analysis of Pulmonary Artery Denervation for Treatment of
Pulmonary Hypertension
por: Zuo, Wanyun, et al.
Publicado: (2022) -
Naringin protects endothelial cells from apoptosis and inflammation by regulating the Hippo-YAP Pathway
por: Zhao, Hui, et al.
Publicado: (2020)